Latest filing published 15 May 2024 for ZeroFox Holdings, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -33.3%Entry US$62.40 · Close at T+365 US$41.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
New Enterprise Associates 14, L.P.: trading record in brief
Filings by New Enterprise Associates 14, L.P. span 15 companies, the busiest being Enliven Therapeutics, Inc., Adaptimmune Therapeutics PLC and Mersana Therapeutics, Inc. Between 6 August 2013 and 13 May 2024, the trades on record add up to 90 filings.
Market trades split into 19 purchases (€109.4M) and 39 sales (€64.0M). The net balance comes to €45.4M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants.
In size, the median ticket on the buying side is €4.5M. Of 16 purchases, 16 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 15 May 2024 with a transaction in ZeroFox Holdings, Inc. The last purchase on record was published on 16 March 2020, which is 2,428 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to New Enterprise Associates 14, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,068,513 sharesCommon StockSEC:0000950170-24-060355:0
- 5,925,287 sharesCommon StockSEC:0001209191-23-001125:0
- 255,463 shares@ US$1.10322.9% of flowCommon StockSEC:0001209191-22-023686:1
- 439,088 shares@ US$1.069167.3% of flowCommon StockSEC:0001209191-22-023686:0
- 6,222,502 shares@ US$6.90100.0% of flowCommon StockSEC:0001209191-22-005111:0
- 19,984 shares@ US$1.55210.3% of flowCommon StockSEC:0001209191-22-004877:1
- 102,952 shares@ US$1.47451.5% of flowCommon StockSEC:0001209191-22-004877:2
- 11,622 shares@ US$1.66832.7% of flowCommon StockSEC:0001209191-22-004877:0
- 13,412 shares@ US$1.82030.2% of flowCommon StockSEC:0001209191-22-004110:1
- 6,295 shares@ US$1.80860.1% of flowCommon StockSEC:0001209191-22-004110:2
- 6,848 shares@ US$1.88771.8% of flowCommon StockSEC:0001209191-22-004110:0
- 7,209 shares@ US$1.92620.1% of flowCommon StockSEC:0001209191-22-003357:1
- 9,707 shares@ US$1.91440.2% of flowCommon StockSEC:0001209191-22-003357:2
- 4,634 shares@ US$2.01931.3% of flowCommon StockSEC:0001209191-22-003357:0
- 1,751 shares@ US$2.000.0% of flowCommon StockSEC:0001209191-22-002930:1
- 2,409 shares@ US$2.04210.0% of flowCommon StockSEC:0001209191-22-002930:2
- 14,600 shares@ US$2.07664.2% of flowCommon StockSEC:0001209191-22-002930:0
- 8,200 shares@ US$2.24870.2% of flowCommon StockSEC:0001209191-22-002224:1
- 10,257 shares@ US$2.16490.2% of flowCommon StockSEC:0001209191-22-002224:2
- 13,459 shares@ US$2.34374.4% of flowCommon StockSEC:0001209191-22-002224:0
- 49,953 shares@ US$2.25031.1% of flowCommon StockSEC:0001209191-22-000354:1
- 44,665 shares@ US$2.33731.0% of flowCommon StockSEC:0001209191-22-000354:2
- 21,858 shares@ US$2.29056.9% of flowCommon StockSEC:0001209191-22-000354:0
- 24,580 shares@ US$2.34090.6% of flowCommon StockSEC:0001209191-21-071531:1
- 15,196 shares@ US$2.30020.4% of flowCommon StockSEC:0001209191-21-071531:2
25 of 86 declarations
